
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting tumor‑associated macrophages in the tumor microenvironment (Review)
Kaiwen Zhou, Tan Cheng, Jinyue Zhan, et al.
Oncology Letters (2020) Vol. 20, Iss. 5, pp. 1-1
Open Access | Times Cited: 83
Kaiwen Zhou, Tan Cheng, Jinyue Zhan, et al.
Oncology Letters (2020) Vol. 20, Iss. 5, pp. 1-1
Open Access | Times Cited: 83
Showing 1-25 of 83 citing articles:
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
Carlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 161
Carlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 161
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
Yueshui Zhao, Sipeng Guo, Jian Min Deng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 9, pp. 3845-3858
Open Access | Times Cited: 133
Yueshui Zhao, Sipeng Guo, Jian Min Deng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 9, pp. 3845-3858
Open Access | Times Cited: 133
The role of tumor-associated macrophages in tumor immune evasion
Ruizhe Huang, Ting Kang, Siyu Chen
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 44
Ruizhe Huang, Ting Kang, Siyu Chen
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 44
Immunological Effects of Histotripsy for Cancer Therapy
Alissa Hendricks-Wenger, Ruby Hutchison, Eli Vlaisavljevich, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 56
Alissa Hendricks-Wenger, Ruby Hutchison, Eli Vlaisavljevich, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 56
Inhibition of the VEGF signaling pathway attenuates tumor‑associated macrophage activity in liver cancer
Shohei Okikawa, Yuji Morine, Yu Saito, et al.
Oncology Reports (2022) Vol. 47, Iss. 4
Open Access | Times Cited: 43
Shohei Okikawa, Yuji Morine, Yu Saito, et al.
Oncology Reports (2022) Vol. 47, Iss. 4
Open Access | Times Cited: 43
β-Glucan extracts as high-value multifunctional ingredients for skin health: A review
Pedro Sousa, Diana Tavares‐Valente, Manuela Amorim, et al.
Carbohydrate Polymers (2023) Vol. 322, pp. 121329-121329
Closed Access | Times Cited: 23
Pedro Sousa, Diana Tavares‐Valente, Manuela Amorim, et al.
Carbohydrate Polymers (2023) Vol. 322, pp. 121329-121329
Closed Access | Times Cited: 23
Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities
Margot Lavy, Vanessa Gauttier, Nicolas Poirier, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 42
Margot Lavy, Vanessa Gauttier, Nicolas Poirier, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 42
Nanozyme-Based Enhanced Cancer Immunotherapy
Ngoc Man Phan, Thanh Loc Nguyen, Jaeyun Kim
Tissue Engineering and Regenerative Medicine (2022) Vol. 19, Iss. 2, pp. 237-252
Open Access | Times Cited: 37
Ngoc Man Phan, Thanh Loc Nguyen, Jaeyun Kim
Tissue Engineering and Regenerative Medicine (2022) Vol. 19, Iss. 2, pp. 237-252
Open Access | Times Cited: 37
Radiomics: A review of current applications and possibilities in the assessment of tumor microenvironment
Caiqiang Xue, Qing Zhou, Huaze Xi, et al.
Diagnostic and Interventional Imaging (2022) Vol. 104, Iss. 3, pp. 113-122
Open Access | Times Cited: 36
Caiqiang Xue, Qing Zhou, Huaze Xi, et al.
Diagnostic and Interventional Imaging (2022) Vol. 104, Iss. 3, pp. 113-122
Open Access | Times Cited: 36
Cancer-associated inflammation: pathophysiology and clinical significance
Piotr Pęczek, Monika Gajda, Kacper Rutkowski, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 6, pp. 2657-2672
Open Access | Times Cited: 33
Piotr Pęczek, Monika Gajda, Kacper Rutkowski, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 6, pp. 2657-2672
Open Access | Times Cited: 33
Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer
Xia Qiu, Tianjiao Zhao, Ran Luo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 29
Xia Qiu, Tianjiao Zhao, Ran Luo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 29
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 7
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 7
Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
Ruiwen Zhao, Olga Sukocheva, Edmund C. M. Tse, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Ruiwen Zhao, Olga Sukocheva, Edmund C. M. Tse, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy
Ryan McWhorter, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 97-125
Closed Access | Times Cited: 6
Ryan McWhorter, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 97-125
Closed Access | Times Cited: 6
T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer
Mehrdad Fathi, Inna Pustokhina, Sergey V. Kuznetsov, et al.
IUBMB Life (2021) Vol. 73, Iss. 5, pp. 726-738
Open Access | Times Cited: 36
Mehrdad Fathi, Inna Pustokhina, Sergey V. Kuznetsov, et al.
IUBMB Life (2021) Vol. 73, Iss. 5, pp. 726-738
Open Access | Times Cited: 36
Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer
Haiyun Zhang, Alexander Steed, Milo Co, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 33
Haiyun Zhang, Alexander Steed, Milo Co, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 33
Immunomodulatory role of metalloproteinase ADAM17 in tumor development
Kai Wang, Zixue Xuan, Xiaoyan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Kai Wang, Zixue Xuan, Xiaoyan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma
Jihao Tu, Duo Wang, XiaoTian Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Jihao Tu, Duo Wang, XiaoTian Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Molecular Changes in Breast Cancer Induced by Radiation Therapy
Kim Sheva, Sangita Roy Chowdhury, Nataly Kravchenko‐Balasha, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 120, Iss. 2, pp. 465-481
Closed Access | Times Cited: 5
Kim Sheva, Sangita Roy Chowdhury, Nataly Kravchenko‐Balasha, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 120, Iss. 2, pp. 465-481
Closed Access | Times Cited: 5
Leptin Augments Antitumor Immunity in Obesity by Repolarizing Tumor-Associated Macrophages
Stephanie O. Dudzinski, Jackie E. Bader, Kathryn E. Beckermann, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 12, pp. 3122-3130
Open Access | Times Cited: 29
Stephanie O. Dudzinski, Jackie E. Bader, Kathryn E. Beckermann, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 12, pp. 3122-3130
Open Access | Times Cited: 29
Clinical evaluation of colony-stimulating factor 1 receptor inhibitors
Peter Ordentlich
Seminars in Immunology (2021) Vol. 54, pp. 101514-101514
Closed Access | Times Cited: 28
Peter Ordentlich
Seminars in Immunology (2021) Vol. 54, pp. 101514-101514
Closed Access | Times Cited: 28
Kezhou Wang, Jie Xiong, Yiwen Lu, et al.
FEBS Journal (2022) Vol. 290, Iss. 1, pp. 209-224
Closed Access | Times Cited: 20
Glutathione S‐transferase omega class 1 (GSTO1 )‐associated large extracellular vesicles are involved in tumor‐associated macrophage‐mediated cisplatin resistance in bladder cancer
Yi‐Cheng Pan, Pei‐Yi Chu, Ching‐Chan Lin, et al.
Molecular Oncology (2024) Vol. 18, Iss. 8, pp. 1866-1884
Open Access | Times Cited: 4
Yi‐Cheng Pan, Pei‐Yi Chu, Ching‐Chan Lin, et al.
Molecular Oncology (2024) Vol. 18, Iss. 8, pp. 1866-1884
Open Access | Times Cited: 4
FAM109B plays a tumorigenic role in low-grade gliomas and is associated with tumor-associated macrophages (TAMs)
Zhe Zhang, Yao Xiao, Siyi Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Zhe Zhang, Yao Xiao, Siyi Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Macrophage-derived extracellular vesicles as new players in chronic non-communicable diseases
Fengjuan Lin, Huiyu Luo, Jiexian Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Fengjuan Lin, Huiyu Luo, Jiexian Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access